On Friday, Zimmer Biomet Holdings Inc (NYSE: ZBH) opened lower -1.25% from the last session, before settling in for the closing price of $93.34. Price fluctuations for ZBH have ranged from $89.92 to $116.71 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -0.77% over the last five years. Company’s average yearly earnings per share was noted -0.42% at the time writing. With a float of $197.57 million, this company’s outstanding shares have now reached $197.90 million.
The firm has a total of 17000 workers. Let’s measure their productivity. In terms of profitability, gross margin is 71.05%, operating margin of 17.04%, and the pretax margin is 13.65%.
Zimmer Biomet Holdings Inc (ZBH) Insider Activity
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Zimmer Biomet Holdings Inc is 0.14%, while institutional ownership is 95.01%. The most recent insider transaction that took place on Mar 05 ’25, was worth 150,649. In this transaction SVP and CHRO of this company sold 1,443 shares at a rate of $104.40, taking the stock ownership to the 8,768 shares. Before that another transaction happened on Mar 05 ’25, when Company’s Officer proposed sale 1,443 for $104.40, making the entire transaction worth $150,653.
Zimmer Biomet Holdings Inc (ZBH) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -0.42% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 4.13% during the next five years compared to -4.13% drop over the previous five years of trading.
Zimmer Biomet Holdings Inc (NYSE: ZBH) Trading Performance Indicators
Check out the current performance indicators for Zimmer Biomet Holdings Inc (ZBH). In the past quarter, the stock posted a quick ratio of 1.46. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.37. Likewise, its price to free cash flow for the trailing twelve months is 14.67.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 4.51, a number that is poised to hit 1.98 in the next quarter and is forecasted to reach 8.30 in one year’s time.
Technical Analysis of Zimmer Biomet Holdings Inc (ZBH)
Analysing the last 5-days average volume posted by the [Zimmer Biomet Holdings Inc, ZBH], we can find that recorded value of 2.73 million was better than the volume posted last year of 2.19 million. As of the previous 9 days, the stock’s Stochastic %D was 34.51%. Additionally, its Average True Range was 2.60.
During the past 100 days, Zimmer Biomet Holdings Inc’s (ZBH) raw stochastic average was set at 9.18%, which indicates a significant decrease from 20.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 26.27% in the past 14 days, which was lower than the 32.26% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $100.94, while its 200-day Moving Average is $105.81. Now, the first resistance to watch is $92.99. This is followed by the second major resistance level at $93.81. The third major resistance level sits at $94.58. If the price goes on to break the first support level at $91.39, it is likely to go to the next support level at $90.62. Should the price break the second support level, the third support level stands at $89.80.
Zimmer Biomet Holdings Inc (NYSE: ZBH) Key Stats
There are currently 197,848K shares outstanding in the company with a market cap of 18.24 billion. Presently, the company’s annual sales total 7,679 M according to its annual income of 903,700 K. Last quarter, the company’s sales amounted to 1,909 M and its income totaled 182,000 K.
